logo

NUS

Nu Skin Enterprises·NYSE
--
--(--)
--
--(--)
9.78 / 10
Outperform

Fundamental score is 9.8/10, rated Outperform. Net profit margin (10.8%) and profit‑to‑revenue (10.8%) are strong, while cash‑to‑market value is weak. Revenue‑MV and Asset‑MV show sizable upside, and ROE (19.9%) is robust, supporting a very promising profile.

Fundamental(9.78)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value1.58
Score3/3
Weight71.66%
1M Return5.57%
Shareholders’ equity attributable to parent company / Total liabilities (%)
Value1.34
Score3/3
Weight30.02%
1M Return2.25%
Operating cycle
Value157.28
Score1/3
Weight-44.81%
1M Return-6.27%
Net cash flow from operating activities / Operating revenue (%)
Value5.41
Score1/3
Weight-36.26%
1M Return-3.73%
Current liabilities / Total liabilities (%)
Value43.95
Score3/3
Weight14.77%
1M Return1.09%
Net profit margin (%)
Value10.79
Score2/3
Weight-25.25%
1M Return-2.22%
ROE (diluted) (%)
Value19.90
Score1/3
Weight-26.91%
1M Return-2.63%
Net profit / Total operating revenue (%)
Value10.79
Score2/3
Weight-25.25%
1M Return-2.22%
Asset-MV
Value-0.55
Score3/3
Weight207.55%
1M Return15.05%
Cash-MV
Value-0.07
Score0/3
Weight-65.52%
1M Return-8.15%
Is NUS fundamentally strong?
  • NUS scores 9.78/10 on fundamentals and holds a Discounted valuation at present. Backed by its 22.00% ROE, 10.79% net margin, 2.19 P/E ratio, 0.44 P/B ratio, and 210.17% earnings growth, these metrics solidify its Outperform investment rating.